Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-Controlled Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia in Patients Receiving Long-term Milnacipran Treatment
NCT01014585 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Placebo-Controlled Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia in Patients Receiving Long-term Milnacipran Treatment
- Lead sponsor
- Forest Laboratories
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- Not reported
- Enrollment
- 340 (actual)
- Sites
- 58
Conditions
As the registry lists them; a condition with its own page is linked.